Return to Trial Database

HCRN-MM02-35

A Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma

Status

Study Completed

Cancer Type(s)

Mutiple Myeloma

Study Contact

Trial Locations

All sites in which the trial HCRN-MM02-35 being conducted in.

No data was found